By: Veronika Litinski
In an increasingly knowledge-based and innovation-driven economy, human brains—not financial capital—are becoming the primary drivers of business success. Engaged, creative citizens and workers mean the difference between success and failure at the organizational and societal levels.
Looking at the problem from the perspective of brain health, there are Read the rest of this entry »
By: Alvaro Fernandez
39% We had several readers highlight this striking statistic from yesterday’s blog post, Is ADHD overdiagnosed? Findings from a new study in Germany
This is but another example on the growing need to base behavioral/ mental health prevention, diagnostic and treatment not on symptoms alone, but to measure and incorporate objective markers of brain function, as discussed in our previous article Neurofeedback/ Quantitative EEG for ADHD diagnosis and in Thomas Insel’s blog post on big data.
By: SharpBrains


Below you can find the full transcript of our engaging Q&A session today, Friday March 16th, on brain sustainability, retooling brain health, and applied neuroplasticity, with Alvaro Fernandez, SharpBrains’ Co-Founder who’s just been named a Young Global Leader by the World Economic Forum. You can learn more about the topic by reading this 2011 SharpBrains Summit Meeting Report and this Infographic.
10:04
Great, we are ready to start! Read the rest of this entry »
By: Alvaro Fernandez
Time for SharpBrains’ February 2012 eNewsletter, featuring in this occasion multiple and complementary perspectives on how to harness neuroplasticity: with enthusiasm, BOTH physical AND cognitive exercise, and (once tools become better standardized and widely available) brain-based personalized medicine.
Featured Perspectives:
What’s New and Meaningful:
SharpBrains News:
Finally, let us mention that Brain Awareness Week is approaching (March 12-18th, 2012), and that you can now add comments to SharpBrains articles via Facebook (see below). Looking forward to a great month of March!
By: SharpBrains

We just came accross an excellent article by Dr. Thomas Insel, Director of the National Institute for Mental Health (NIMH), titled An Emerging Era of Big Data. The article is brief and worth reading. Here are two quotes:
- “Every era has its technological icons. In the early 20th century, it was the airplane and the automobile. In the mid-20th century, it was the television and the telephone. Now in the early 21st century, the smart phone and social networking appear to be the defining technologies. And increasingly, the current era is beginning to look like the era of “big data” — a term that Read the rest of this entry »
By: Dr. Evian Gordon

(Editor’s Note: this is Part 1 of the new 3-part series written by Dr. Evian Gordon drawing from his participation at the Personalized Medicine World Congress on January, 23, 2012 at Stanford University.)
On average, the medications prescribed for brain-related conditions benefit approximately 50% of patients. But which 50%?
Personalized Medicine seeks to move away from the current “1 size fits all, trial and error” approach that has been necessary because of a lack of evidence. Instead, it focuses on Read the rest of this entry »
By: Alvaro Fernandez
“On average, the medications prescribed for brain-related conditions benefit approximately 50% of patients. But which 50%?.”
“We need unambiguous biomarkers that are clinically relevant and scalable at reasonable cost. They already exist in Cancer. But they do not yet exist in the Brain.” What may change that? Read the rest of this entry »